Development of murine leukemia virus-based retroviral vectors with a minimum possibility of cis-activation.

about

Development of murine leukemia virus-based retroviral vectors with a minimum possibility of cis-activation.

Item

http://www.wikidata.org/entity/Q39644492

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

2010年论文

@zh

2010年论文

@zh-cn

name

Development of murine leukemia ...... possibility of cis-activation.

@en

Development of murine leukemia ...... possibility of cis-activation.

@nl

type

Item

label

Development of murine leukemia ...... possibility of cis-activation.

@en

Development of murine leukemia ...... possibility of cis-activation.

@nl

prefLabel

Development of murine leukemia ...... possibility of cis-activation.

@en

Development of murine leukemia ...... possibility of cis-activation.

@nl

P1476

Development of murine leukemia ...... possibility of cis-activation

@en

P2093

J Y Kim

http://www.w3.org/2001/XMLSchema#string

J-T Lee

http://www.w3.org/2001/XMLSchema#string

K Lee

http://www.w3.org/2001/XMLSchema#string

S Kim

http://www.w3.org/2001/XMLSchema#string

P2860

Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells

Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease

LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1

Genomic organization of a cDNA (QM) demonstrating an altered mRNA level in nontumorigenic Wilms' microcell hybrid cells and its localization to Xq28

Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy

Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1

Comprehensive analysis of transcriptional promoter structure and function in 1% of the human genome

Gene expression from transcriptionally disabled retroviral vectors.

Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1.

Self-inactivating retroviral vectors designed for transfer of whole genes into mammalian cells

P2888

gt.2010.135

P304

240-249

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/GT.2010.135

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Keejung Yoon

Jiwon Jang

P577

2010-10-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

47415559

http://www.w3.org/2001/XMLSchema#string

P698

20944681

http://www.w3.org/2001/XMLSchema#string

P921

vector-borne disease